Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transmission of HIV-1 drug resistance in Benin could jeopardise future treatment options.

Sexually transmitted infections - 1 Apr 2012

Chamberland Annie, Diabaté Souleymane, Sylla Mohamed, Anagounou Séverin, Geraldo Nassirou, Zannou Djimon Marcel, Labbé Annie-Claude, Worobey Michael, Alary Michel, Tremblay Cécile

Abstract excerpt

OBJECTIVES: As access to antiretrovirals (ARV) increases in developing countries, the identification of optimal therapeutic regimens and prevention strategies requires the identification of resistance pathways in non-B subtypes as well as the surveillance of drug mutation resistance (SDMR) includ...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Benin
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Molecular Epidemiology

Share to Plasma

Source

Identifiers

PMID: 22158948
DOI: 10.1136/sextrans-2011-050209

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Prepared record publication-22158948-2026-09-05.1. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transmission of HIV-1 drug resistance in Benin could jeopardise future treatment options.PMID 22158948Read ↗

Moderate rate of transmitted resistance mutations to antiretrovirals and genetic diversity in newly HIV-1 patients diagnosed in Benin.Semantic proximity Read ↗

Moderate rate of transmitted resistance mutations to antiretrovirals and genetic diversity in newly HIV-1 patients diagnosed in Benin.Semantic proximity Read ↗

Alarming rate of transmitted drug resistance mutations and genetic diversity in newly HIV-1-infected patients in BeninSemantic proximity Read ↗

HIV-1 genetic diversity and reverse transcriptase resistance mutations in Benin before dolutegravir era, West Africa.Semantic proximity Read ↗

Drug-resistance surveillance among newly HIV-1 diagnosed individuals in Buenos Aires, Argentina.Semantic proximity Read ↗

Increasing trends in primary NNRTI resistance among newly HIV-1-diagnosed individuals in Buenos Aires, Argentina.Semantic proximity Read ↗

[Primary HIV resistance in Buenos Aires metropolitan area].Semantic proximity Read ↗

Drug resistance in non-subtype B HIV-1.Semantic proximity Read ↗

High prevalence of HIV-1 transmitted drug resistance among therapy-naïve Burmese entering travelers at Dehong ports in Yunnan, China.Semantic proximity Read ↗

High frequency of antiviral drug resistance and non-B subtypes in HIV-1 patients failing antiviral therapy in Cuba.Semantic proximity Read ↗

Current Resistance of HIV-1 Strains Isolated in Volunteer Blood Donors in Gabon.Semantic proximity Read ↗

Transmitted HIV drug resistance in treatment-naive Romanian patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.